Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.89 - $1.39 $6,426 - $10,037
-7,221 Reduced 65.74%
3,763 $4,000
Q1 2023

May 09, 2023

BUY
$1.06 - $3.05 $4,837 - $13,920
4,564 Added 71.09%
10,984 $12,000
Q4 2022

Feb 10, 2023

BUY
$0.56 - $2.61 $3,595 - $16,756
6,420 New
6,420 $12,000
Q2 2022

Aug 15, 2022

BUY
$1.13 - $2.66 $18,415 - $43,350
16,297 Added 370.72%
20,693 $30,000
Q1 2022

May 12, 2022

SELL
$1.68 - $5.01 $1,055 - $3,146
-628 Reduced 12.5%
4,396 $10,000
Q4 2021

Feb 14, 2022

SELL
$4.02 - $16.84 $33,856 - $141,826
-8,422 Reduced 62.64%
5,024 $22,000
Q3 2021

Nov 15, 2021

BUY
$9.26 - $31.31 $101,017 - $341,560
10,909 Added 430.0%
13,446 $212,000
Q2 2021

Aug 16, 2021

BUY
$9.37 - $12.12 $10,250 - $13,259
1,094 Added 75.81%
2,537 $26,000
Q1 2021

May 17, 2021

SELL
$10.61 - $15.77 $10,111 - $15,028
-953 Reduced 39.77%
1,443 $16,000
Q4 2020

Feb 16, 2021

SELL
$10.21 - $17.31 $118,384 - $200,709
-11,595 Reduced 82.87%
2,396 $30,000
Q3 2020

Nov 16, 2020

BUY
$9.99 - $16.13 $116,623 - $188,301
11,674 Added 503.84%
13,991 $186,000
Q2 2020

Aug 13, 2020

BUY
$11.21 - $18.15 $25,973 - $42,053
2,317 New
2,317 $35,000
Q1 2020

May 15, 2020

SELL
$9.68 - $18.47 $6,698 - $12,781
-692 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$11.83 - $18.68 $6,447 - $10,180
-545 Reduced 44.06%
692 $11,000
Q3 2019

Nov 05, 2019

BUY
$15.33 - $23.85 $18,963 - $29,502
1,237 New
1,237 $22,000
Q2 2019

Aug 13, 2019

SELL
$13.36 - $23.7 $7,949 - $14,101
-595 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$16.01 - $19.96 $960 - $1,197
60 Added 11.21%
595 $10,000
Q4 2018

Feb 14, 2019

SELL
$17.15 - $26.08 $1,440 - $2,190
-84 Reduced 13.57%
535 $10,000
Q3 2018

Nov 13, 2018

BUY
$19.31 - $27.15 $11,952 - $16,805
619 New
619 $15,000
Q2 2018

Aug 15, 2018

SELL
$26.29 - $33.0 $7,518 - $9,438
-286 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$20.39 - $33.94 $5,831 - $9,706
286 New
286 $7,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $91.5M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.